ETCIA yields 666666.67% · MRK yields 2.76%● Live data
📍 ETCIA pulled ahead of the other in Year 1
Combined, ETCIA + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ETCIA + MRK for your $10,000?
Electronic Tele-Communications, Inc. designs, manufactures, markets, leases, and sells digital voice information systems and related services to the telecommunications industry and other businesses. Its equipment provides a range of audio and computer information, and call handling capabilities through telephone networks, computer networks, and the Internet. The company's digital voice information systems deliver network interoperability, as well as applications, including branding, time and temperature announcements, weather forecasts, automatic callback, changed number with call completion, repeat dialing, and wake-up/reminder services. It offers Digicept Emcee ELF3 and Digicept Emcee ELF that provide applications and services in a single platform for circuit and packet-switched networks; Audichron Z-10, a time-temperature-weather announcer; Audichron Z-10 MCA, a multi-channel announcer; digital announcement systems; professional recording services; weathertel forecasting services; and MAX Terminator, which offers disconnect detection to eliminate tied-up lines and annoying tones. The company also provides installation, repair, maintenance, and weather update services, as well as professional recording of announcements; turn-key installations; and on-site training and technical support services. It serves regional bell operating companies, competitive local exchange carriers, independent telephone companies, long distance companies, wireless carriers, cable companies, telecommunications manufacturers, utilities, and other businesses and organizations. The company was incorporated in 1980 and is based in Waukesha, Wisconsin.
Full ETCIA Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.